Answers are grounded in this paper and cite their sources.
This article discusses the recent regulatory restrictions on the use of fluoroquinolones and their impact on treating orthopaedic infections. We focus on the balance between the benefits and risks of fluoroquinolones in scenarios involving severe infections where alternative antibiotics may be less effective. The discussion includes a summary of recent evidence on adverse effects and the implications for clinical practice.
No takes yet. Share an insight, caveat, or question.
Azamgarhi et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: